Obsidian Therapeutics Appoints Dana Alexander as Chief Technical Officer

Wednesday, 8 May 2024
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Obsidian Therapeutics, Inc., a clinical-stage biotechnology company pioneering engineered cell and gene therapies, today announced the appointment of Dana Alexander as Chief Technical Officer. “Dana has over two decades of operational expertise across cell therapy, gene therapy and biologics process development and chemistry, manufacturing, and controls (CMC), from Phase 1 through commercialization,” said Madan Jagasia, M.D., Chief Executive Officer of Obsidia

👓 View full article

0 shares	Share Tweet Save Post Send

Obsidian Therapeutics Appoints Dana Alexander as Chief Technical Officer

You Might Like